Appleton Partners Inc Novartis Ag Transaction History

Appleton Partners Inc

$1.36 Billion
Q3 2024

A detailed history of Appleton Partners Inc transactions in Novartis Ag stock. As of the latest transaction made, Appleton Partners Inc holds 2,047 shares of NVS stock, worth $198,722. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,047

Previous 2,106 2.8%

Holding current value

$198,722

Previous $224,000 4.91%

% of portfolio

0.02%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 01, 2024	SELL	$106.13 - $120.89 $6,261 - $7,132	-59 Reduced 2.8%	2,047 $235,000
Q2 2024 Jul 02, 2024	SELL	$92.57 - $107.37 $10,090 - $11,703	-109 Reduced 4.92%	2,106 $224,000
Q1 2024 Apr 01, 2024	SELL	$95.27 - $108.47 $28,485 - $32,432	-299 Reduced 11.89%	2,215 $214,000
Q4 2023 Jan 02, 2024	SELL	$92.27 - $101.54 $1,660 - $1,827	-18 Reduced 0.71%	2,514 $254,000
Q3 2023 Oct 03, 2023	SELL	$94.73 - $105.13 $47,933 - $53,195	-506 Reduced 16.66%	2,532 $258,000
Q2 2023 Jul 10, 2023	BUY	$92.52 - $104.91 $5,088 - $5,770	55 Added 1.84%	3,038 $307,000
Q1 2023 Apr 10, 2023	BUY	$80.03 - $92.81 $238,729 - $276,852	2,983 New	2,983 $274,000
Q4 2021 Feb 03, 2022	BUY	$79.7 - $88.13 $214,074 - $236,717	2,686 New	2,686 $235,000
Q3 2021 Oct 14, 2021	SELL	$81.78 - $95.14 $333,989 - $388,551	-4,084 Closed	0 $0
Q2 2021 Jul 07, 2021	SELL	$85.24 - $94.15 $60,435 - $66,752	-709 Reduced 14.79%	4,084 $373,000
Q1 2021 Apr 19, 2021	BUY	$83.5 - $98.47 $34,652 - $40,865	415 Added 9.48%	4,793 $410,000
Q4 2020 Jan 19, 2021	SELL	$78.07 - $94.43 $780 - $944	-10 Reduced 0.23%	4,378 $413,000
Q1 2020 May 04, 2020	SELL	$70.67 - $99.01 $33,002 - $46,237	-467 Reduced 9.62%	4,388 $362,000
Q4 2019 Jan 13, 2020	SELL	$84.35 - $95.37 $29,353 - $33,188	-348 Reduced 6.69%	4,855 $460,000
Q3 2019 Nov 04, 2019	BUY	$85.54 - $94.26 $7,527 - $8,294	88 Added 1.72%	5,203 $452,000
Q2 2019 Jul 25, 2019	SELL	$75.4 - $92.8 $16,286 - $20,044	-216 Reduced 4.05%	5,115 $467,000
Q1 2019 Apr 17, 2019	BUY	$75.32 - $86.15 $6,477 - $7,408	86 Added 1.64%	5,331 $513,000
Q4 2018 Jan 17, 2019	BUY	$73.66 - $82.02 $46,037 - $51,262	625 Added 13.53%	5,245 $450,000
Q3 2018 Oct 09, 2018	SELL	$66.94 - $77.43 $58,237 - $67,364	-870 Reduced 15.85%	4,620 $398,000
Q2 2018 Aug 08, 2018	SELL	$64.91 - $73.36 $263,599 - $297,914	-4,061 Reduced 42.52%	5,490 $415,000
Q1 2018 Apr 11, 2018	SELL	$70.39 - $84.15 $19,075 - $22,804	-271 Reduced 2.76%	9,551 $772,000
Q4 2017 Jan 12, 2018	BUY	$72.33 - $77.64 $2,531 - $2,717	35 Added 0.36%	9,822 $825,000
Q3 2017 Oct 12, 2017	BUY	$74.14 - $77.27 $725,608 - $756,241	9,787	9,787 $840,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Appleton Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on Appleton Partners Inc with notifications on news.

Account

Appleton Partners Inc Novartis Ag Transaction History